Annual EBITDA
$1.12 B
+$394.00 M+54.27%
31 December 2023
Summary:
Xylem annual earnings before interest, taxes, depreciation & amortization is currently $1.12 billion, with the most recent change of +$394.00 million (+54.27%) on 31 December 2023. During the last 3 years, it has risen by +$507.00 million (+82.71%). XYL annual EBITDA is now at all-time high.XYL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$420.00 M
+$17.00 M+4.22%
30 September 2024
Summary:
Xylem quarterly earnings before interest, taxes, depreciation & amortization is currently $420.00 million, with the most recent change of +$17.00 million (+4.22%) on 30 September 2024. Over the past year, it has increased by +$74.00 million (+21.39%). XYL quarterly EBITDA is now at all-time high.XYL Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$1.53 B
+$74.00 M+5.09%
30 September 2024
Summary:
Xylem TTM earnings before interest, taxes, depreciation & amortization is currently $1.53 billion, with the most recent change of +$74.00 million (+5.09%) on 30 September 2024. Over the past year, it has increased by +$507.00 million (+49.66%). XYL TTM EBITDA is now at all-time high.XYL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XYL EBITDA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +54.3% | +21.4% | +49.7% |
3 y3 years | +82.7% | +94.4% | +74.6% |
5 y5 years | +20.7% | +508.7% | +104.8% |
XYL EBITDA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +82.7% | at high | +382.8% | at high | +130.8% |
5 y | 5 years | at high | +82.7% | at high | +508.7% | at high | +170.9% |
alltime | all time | at high | +197.1% | at high | +508.7% | at high | +1560.9% |
Xylem EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $420.00 M(+4.2%) | $1.53 B(+5.1%) |
June 2024 | - | $403.00 M(+17.2%) | $1.45 B(+14.6%) |
Mar 2024 | - | $344.00 M(-4.7%) | $1.27 B(+13.3%) |
Dec 2023 | $1.12 B(+54.3%) | $361.00 M(+4.3%) | $1.12 B(+9.7%) |
Sept 2023 | - | $346.00 M(+58.7%) | $1.02 B(+34.0%) |
June 2023 | - | $218.00 M(+11.8%) | $762.00 M(+1.3%) |
Mar 2023 | - | $195.00 M(-25.6%) | $752.00 M(+3.6%) |
Dec 2022 | $726.00 M(-12.7%) | $262.00 M(+201.1%) | $726.00 M(+9.7%) |
Sept 2022 | - | $87.00 M(-58.2%) | $662.00 M(-16.3%) |
June 2022 | - | $208.00 M(+23.1%) | $791.00 M(-1.6%) |
Mar 2022 | - | $169.00 M(-14.6%) | $804.00 M(-3.4%) |
Dec 2021 | $832.00 M(+35.7%) | $198.00 M(-8.3%) | $832.00 M(-4.9%) |
Sept 2021 | - | $216.00 M(-2.3%) | $875.00 M(+10.2%) |
June 2021 | - | $221.00 M(+12.2%) | $794.00 M(+15.4%) |
Mar 2021 | - | $197.00 M(-18.3%) | $688.00 M(+12.2%) |
Dec 2020 | $613.00 M(-17.2%) | $241.00 M(+78.5%) | $613.00 M(-2.7%) |
Sept 2020 | - | $135.00 M(+17.4%) | $630.00 M(+11.7%) |
June 2020 | - | $115.00 M(-5.7%) | $564.00 M(-17.8%) |
Mar 2020 | - | $122.00 M(-52.7%) | $686.00 M(-7.3%) |
Dec 2019 | $740.00 M(-20.3%) | $258.00 M(+273.9%) | $740.00 M(-0.8%) |
Sept 2019 | - | $69.00 M(-70.9%) | $746.00 M(-19.1%) |
June 2019 | - | $237.00 M(+34.7%) | $922.00 M(+0.1%) |
Mar 2019 | - | $176.00 M(-33.3%) | $921.00 M(-0.8%) |
Dec 2018 | $928.00 M(+18.7%) | $264.00 M(+7.8%) | $928.00 M(+4.5%) |
Sept 2018 | - | $245.00 M(+3.8%) | $888.00 M(+4.1%) |
June 2018 | - | $236.00 M(+29.0%) | $853.00 M(+4.5%) |
Mar 2018 | - | $183.00 M(-18.3%) | $816.00 M(+4.3%) |
Dec 2017 | $782.00 M | $224.00 M(+6.7%) | $782.00 M(+8.3%) |
Sept 2017 | - | $210.00 M(+5.5%) | $722.00 M(+10.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2017 | - | $199.00 M(+33.6%) | $655.00 M(+9.3%) |
Mar 2017 | - | $149.00 M(-9.1%) | $599.00 M(+6.8%) |
Dec 2016 | $561.00 M(-5.1%) | $164.00 M(+14.7%) | $561.00 M(-1.6%) |
Sept 2016 | - | $143.00 M(0.0%) | $570.00 M(-1.7%) |
June 2016 | - | $143.00 M(+28.8%) | $580.00 M(+0.7%) |
Mar 2016 | - | $111.00 M(-35.8%) | $576.00 M(-2.5%) |
Dec 2015 | $591.00 M(-4.2%) | $173.00 M(+13.1%) | $591.00 M(-0.5%) |
Sept 2015 | - | $153.00 M(+10.1%) | $594.00 M(-3.9%) |
June 2015 | - | $139.00 M(+10.3%) | $618.00 M(-2.2%) |
Mar 2015 | - | $126.00 M(-28.4%) | $632.00 M(+2.4%) |
Dec 2014 | $617.00 M(+22.7%) | $176.00 M(-0.6%) | $617.00 M(+2.5%) |
Sept 2014 | - | $177.00 M(+15.7%) | $602.00 M(+7.9%) |
June 2014 | - | $153.00 M(+37.8%) | $558.00 M(+8.8%) |
Mar 2014 | - | $111.00 M(-31.1%) | $513.00 M(+2.0%) |
Dec 2013 | $503.00 M(-14.0%) | $161.00 M(+21.1%) | $503.00 M(+3.9%) |
Sept 2013 | - | $133.00 M(+23.1%) | $484.00 M(-3.4%) |
June 2013 | - | $108.00 M(+6.9%) | $501.00 M(-9.6%) |
Mar 2013 | - | $101.00 M(-28.9%) | $554.00 M(-5.3%) |
Dec 2012 | $585.00 M(+8.9%) | $142.00 M(-5.3%) | $585.00 M(+1.7%) |
Sept 2012 | - | $150.00 M(-6.8%) | $575.00 M(+5.7%) |
June 2012 | - | $161.00 M(+22.0%) | $544.00 M(+1.9%) |
Mar 2012 | - | $132.00 M(0.0%) | $534.00 M(-0.4%) |
Dec 2011 | $537.00 M(+11.9%) | $132.00 M(+10.9%) | $536.00 M(-0.7%) |
Sept 2011 | - | $119.00 M(-21.2%) | $540.00 M(+1.7%) |
June 2011 | - | $151.00 M(+12.7%) | $531.00 M(+39.7%) |
Mar 2011 | - | $134.00 M(-1.5%) | $380.00 M(+12.4%) |
Dec 2010 | $480.00 M(+27.3%) | $136.00 M(+23.6%) | $338.00 M(+67.3%) |
Sept 2010 | - | $110.00 M(+19.6%) | $202.00 M(+119.6%) |
Mar 2010 | - | $92.00 M | $92.00 M |
Dec 2009 | $377.00 M | - | - |
FAQ
- What is Xylem annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Xylem?
- What is Xylem annual EBITDA year-on-year change?
- What is Xylem quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Xylem?
- What is Xylem quarterly EBITDA year-on-year change?
- What is Xylem TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Xylem?
- What is Xylem TTM EBITDA year-on-year change?
What is Xylem annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of XYL is $1.12 B
What is the all time high annual EBITDA for Xylem?
Xylem all-time high annual earnings before interest, taxes, depreciation & amortization is $1.12 B
What is Xylem annual EBITDA year-on-year change?
Over the past year, XYL annual earnings before interest, taxes, depreciation & amortization has changed by +$394.00 M (+54.27%)
What is Xylem quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of XYL is $420.00 M
What is the all time high quarterly EBITDA for Xylem?
Xylem all-time high quarterly earnings before interest, taxes, depreciation & amortization is $420.00 M
What is Xylem quarterly EBITDA year-on-year change?
Over the past year, XYL quarterly earnings before interest, taxes, depreciation & amortization has changed by +$74.00 M (+21.39%)
What is Xylem TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of XYL is $1.53 B
What is the all time high TTM EBITDA for Xylem?
Xylem all-time high TTM earnings before interest, taxes, depreciation & amortization is $1.53 B
What is Xylem TTM EBITDA year-on-year change?
Over the past year, XYL TTM earnings before interest, taxes, depreciation & amortization has changed by +$507.00 M (+49.66%)